An update from Graft Polymer (UK) PLC ( (GB:SVNS) ) is now available.
Solvonis Therapeutics PLC, a company in the pharmaceutical industry, has announced a change in its major holdings. Steven Myers has acquired or disposed of voting rights, resulting in a 5.11% holding in the company. This change reflects a significant shift in the ownership structure, potentially impacting the company’s governance and strategic direction.
More about Graft Polymer (UK) PLC
YTD Price Performance: -22.50%
Average Trading Volume: 13,002,774
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £3.56M
Find detailed analytics on SVNS stock on TipRanks’ Stock Analysis page.